Patrick Soon-Shiong
Overview
- Source of Wealth
- Pharmaceuticals
- Industry
- Healthcare
- Residence
- Los Angeles, California
- Education
- University of British Columbia (Master of Science)University of Witwatersrand (Bachelor of Arts/Science)University of Witwatersrand (Medical Doctor)
- Marital Status
- Married
- Children
- 2
Assets
- Allscripts3,071,000 shares @ --MDRX-US
- Benitec Biopharma293,000 shares @ --BNTC-US
- Bristol-Myers Squibb Co.9,514,000 shares @ --BMY-US
- Celgene Corporation0 shares @ --CELG-US
- Contingent Value Rights for Celgene Corporation0 shares @ --CELGZ-US
- Directa Plus41,197,000 shares @ --DCTA-GB
- ImmunityBio Inc900,000 shares @ --IBRX-US
- ImmunityBio Inc644,175,000 shares @ --IBRX-US
- JAKKS Pacific Inc.0 shares @ --JAKK-US
- Liminal BioSciences0 shares @ --LMNL-CA
- NantHealth52,464,000 shares @ --NHIQ-US
- RadNet Inc.561,000 shares @ --RDNT-US
- Sorrento Therapeutics0 shares @ --SRNE-US
- Tribune Publishing0 shares @ --TPCO-US
Biography
Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer.
He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion.
He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016.
He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers.
He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.
In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.
About
Soon-Shiong graduated from high school at age 16 and became a doctor at 23.
Soon-Shiong was born in South Africa to Chinese immigrants.